PAOG Cannabis Biopharma M&A Repositions Company For Growth Stock Valuation
SANDUSKY, Ohio, Aug. 13, 2020 /PRNewswire/ — PAO Group, Inc. (USOTC: PAOG) today announced Goldman Small Cap Research has published an initial analyst report covering PAOG’s outlook following two recent acquisitions moving the company into the cannabis biopharma market sector. The report highlights that recent acquisitions have repositioned PAOG for growth in a sector with market cap valuations as high as $100 million. As an example, to illustrate PAOG’s potential for an increased market cap,…
